Suppliers / Heilongjiang Weikaier Biotechnology

Heilongjiang Weikaier Biotechnology

China Updated 9 July 2026

Heilongjiang Weikaier Biotechnology is an API manufacturer based in China. It holds one active US drug master file.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Sirolimus US FDA 1

Also appears on these molecule pages

Sirolimus API

Questions about Heilongjiang Weikaier Biotechnology

Does Heilongjiang Weikaier Biotechnology hold a US DMF or a CEP?
Heilongjiang Weikaier Biotechnology holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Heilongjiang Weikaier Biotechnology make?
1 molecule is on record against Heilongjiang Weikaier Biotechnology, including Sirolimus. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Heilongjiang Weikaier Biotechnology comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Biocon shares 1 molecule Apotex shares 1 molecule BrightGene Bio-Medical shares 1 molecule Concord Biotech shares 1 molecule Livzon Group Fuzhou Fuxing Pharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability